Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 14;15(18):3987.
doi: 10.3390/nu15183987.

Dietary Patterns, Foods, and Nutrients to Ameliorate Non-Alcoholic Fatty Liver Disease: A Scoping Review

Sofía Montemayor  1   2 , Silvia García  1   2   3 , Margalida Monserrat-Mesquida  1   2   3 , Josep A Tur  1   2   3 , Cristina Bouzas  1   2   3
Affiliations

Dietary Patterns, Foods, and Nutrients to Ameliorate Non-Alcoholic Fatty Liver Disease: A Scoping Review

Sofía Montemayor et al. Nutrients. .

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease without pharmacological treatment yet. There is also a lack of specific dietary recommendations and strategies to treat the negative health impacts derived from NAFLD.

Objective: This scoping review aimed to compile dietary patterns, foods, and nutrients to ameliorate NAFLD.

Methods: A literature search was performed through MEDLINE, Scopus, Web of Science, and Google Scholar.

Results: Several guidelines are available through the literature. Hypocaloric Mediterranean diet is the most accepted dietary pattern to tackle NAFLD. Coffee consumption (sugar free) may have a protective effect for NAFLD. Microbiota also plays a role in NAFLD; hence, fibre intake should be guaranteed.

Conclusions: A high-quality diet could improve liver steatosis. Weight loss through hypocaloric diet together with physical activity and limited sugar intake are good strategies for managing NAFLD. Specific dietary recommendations and a Mediterranean plate have been proposed to ameliorate NAFLD.

Keywords: NAFLD; dietary guidelines; dietary recommendations; food; liver steatosis; nutrients.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
NAFLD diet recommendations. Abbreviations: MUFAs, monounsaturated fatty acids; PUFAs, polyunsaturated fatty acids.
Figure 2
Figure 2
The Mediterranean NAFLD plate. A guideline on daily intake for NAFLD patients.
See this image and copyright information in PMC

References

    1. Ekstedt M., Nasr P., Kechagias S. Natural History of NAFLD/NASH. Curr. Hepatol. Rep. 2017;16:391–397. doi: 10.1007/s11901-017-0378-2. - DOI - PMC - PubMed
    1. Riazi K., Azhari H., Charette J.H., E Underwood F., A King J., Afshar E.E., Swain M.G., E Congly S., Kaplan G.G., Shaheen A.-A. The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 2022;7:851–861. doi: 10.1016/S2468-1253(22)00165-0. - DOI - PubMed
    1. Kanwal F., Kramer J.R., Mapakshi S., Natarajan Y., Chayanupatkul M., Richardson P.A., Li L., Desiderio R., Thrift A.P., Asch S.M., et al. Risk of Hepatocellular Cancer in Patients with Non-Alcoholic Fatty Liver Disease. Gastroenterology. 2018;155:1828–1837.e2. doi: 10.1053/j.gastro.2018.08.024. - DOI - PMC - PubMed
    1. GBD 2017 Cirrhosis Collaborators The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5:245–266. doi: 10.1016/S2468-1253(19)30349-8. - DOI - PMC - PubMed
    1. Global Burden of Disease Cancer Collaboration. Fitzmaurice C., Abate D., Abbasi N., Abbastabar H., Abd-Allah F., Abdel-Rahman O., Abdelalim A., Abdoli A., Abdollahpour I., et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2019;5:1749–1768. - PMC - PubMed

Publication types